Atlas Trials

A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

Clinical trial NCT04083235 · COMPLETED

Trial details

NCT number
NCT04083235
Sponsor
Ipsen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Adenocarcinoma of the Pancreas
Start date
2020-02-11
Primary completion
2022-07-23
Enrollment
770

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.